Traws Pharma
TRAW
TRAW
19 hedge funds and large institutions have $1.87M invested in Traws Pharma in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$25.4K | |
2 | +$23.8K | |
3 | +$3.47K | |
4 |
Raymond James Financial
St Petersburg,
Florida
|
+$151 |
5 |
Citigroup
New York
|
+$89 |
Top Sellers
1 | -$970K | |
2 | -$76.6K | |
3 | -$37.3K | |
4 |
Millennium Management
New York
|
-$23.2K |
5 |
UBS Group
Zurich,
Switzerland
|
-$16.8K |